Amedeo's Top 20

Amedeo Smart

Independent Medical Education


26 February 2024

Multidisciplinary Journal Club

  1. Siliciano JD, Siliciano RF.
    HIV cure: The daunting scale of the problem.
    Science 2024;383:703-705.

  1. Vermersch P, Granziera C, Mao-Draayer Y, Cutter G, et al.
    Inhibition of CD40L with Frexalimab in Multiple Sclerosis.
    N Engl J Med 2024;390:589-600.

  2. Guo C, Harshfield EL, Markus HS.
    Sleep Characteristics and Risk of Stroke and Dementia: An Observational and Mendelian Randomization Study.
    Neurology 2024;102:e209141.

  3. Wu J, Heidelberg RE, Gajjar A.
    Adolescents and Young Adults With Cancer: CNS Tumors.
    J Clin Oncol 2024;42:686-695.

  4. Noetel M, Sanders T, Gallardo-Gomez D, Taylor P, et al.
    Effect of exercise for depression: systematic review and network meta-analysis of randomised controlled trials.
    BMJ 2024;384:e075847.

  1. Sarraj A, Abraham MG, Hassan AE, Blackburn S, et al.
    Endovascular thrombectomy plus medical care versus medical care alone for large ischaemic stroke: 1-year outcomes of the SELECT2 trial.
    Lancet 2024.

  2. Altshuler B, Bikas A, Pappa T, Marqusee E, et al.
    Non-Operative, Active Surveillance of Larger Malignant and Suspicious Thyroid Nodules.
    J Clin Endocrinol Metab 2024.

  3. Camus V, Thieblemont C, Gaulard P, Cheminant M, et al.
    Romidepsin Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Versus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Final Analysis of the Ro-CH
    J Clin Oncol 2024.

  4. Zheng G, Faber MT, Wang J, Baandrup L, et al.
    Low-dose aspirin use and risk of ovarian cancer: a combined analysis from two nationwide studies in Denmark and Sweden.
    Br J Cancer 2024.

  5. Geyer CE Jr, Blum JL, Yothers G, Asmar L, et al.
    Long-Term Follow-Up of the Anthracyclines in Early Breast Cancer Trials (USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 [NRG Oncology]).
    J Clin Oncol 2024.

  1. Giacoppo D, Laudani C, Occhipinti G, Spagnolo M, et al.
    Coronary Angiography, Intravascular Ultrasound, and Optical Coherence Tomography in the Guidance of Percutaneous Coronary Intervention: A Systematic Review and Network Meta-Analysis.
    Circulation 2024.

  2. Bakris GL, Saxena M, Gupta A, Chalhoub F, et al.
    RNA Interference With Zilebesiran for Mild to Moderate Hypertension: The KARDIA-1 Randomized Clinical Trial.
    JAMA 2024.

  3. Espinosa De Ycaza AE, Brito JP, McCoy R, Shao H, et al.
    GLP-1 receptor agonists and thyroid cancer: a narrative review.
    Thyroid 2024.

  4. Roberti R, Di Gennaro G, Anzellotti F, Arnaldi D, et al.
    A real-world comparison among third-generation antiseizure medications: Results from the COMPARE study.
    Epilepsia 2024;65:456-472.

  5. Yaghi S, Shu L, Mandel DM, Leon Guerrero CR, et al.
    Antithrombotic Treatment for Stroke Prevention in Cervical Artery Dissection: The STOP-CAD Study.
    Stroke 2024.

  1. Orkin C, Antinori A, Rockstroh JK, Moreno-Guillen S, et al.
    Switch to bictegravir/emtricitabine/tenofovir alafenamide from dolutegravir-based therapy: 96-week pooled analysis.
    AIDS 2024.

  2. Kerlikowske K, Zhu W, Su YR, Sprague BL, et al.
    Supplemental magnetic resonance imaging plus mammography compared with magnetic resonance imaging or mammography by extent of breast density.
    J Natl Cancer Inst 2024;116:249-257.

  3. Collongues N, Durand-Dubief F, Lebrun-Frenay C, Audoin B, et al.
    Cancer and multiple sclerosis: 2023 recommendations from the French Multiple Sclerosis Society.
    Mult Scler 2024.

  4. Punia V, Daruvala S, Dhakar MB, Zafar SF, et al.
    Immediate and long-term management practices of acute symptomatic seizures and epileptiform abnormalities: A cross-sectional international survey.
    Epilepsia 2024.

  5. Gao L, Medford A, Spring L, Bar Y, et al.
    Searching for the "Holy Grail" of breast cancer recurrence risk: a narrative review of the hunt for a better biomarker and the promise of circulating tumor DNA (ctDNA).
    Breast Cancer Res Treat 2024.


more..


Privacy Policy